Clarity of the regulatory time line would have been the trigger...

Clarity of the regulatory time line would have been the trigger for many. Hence the new volume.

Lots of good news coming in the short term to support the price too:
- confirmation of AdComm review date in the next week
- confirmation of PDUFA. Date
- Zogenix FDA decision within a few weeks (probably the more significant of the three)

All this should lead to updated broker reports, articles and further interest.

Good times ahead.

(How's that bone healing P?)